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The Candida albicans transcription factor Efg1 is known to be involved in many different cellular processes, including morpho-
genesis, general metabolism, and virulence. Here we show that besides its manifold roles, Efg1 also has a prominent effect on cell
wall structure and composition, strongly affecting the structural glucan part. Deletion of only one allele of EFG1 already results
in severe phenotypes for cell wall biogenesis, comparable to those with deletion of both alleles, indicative of a severe haploinsuf-
ficiency for EFG1. The observed defects in structural setup of the cell wall, together with previously reported alterations in ex-
pression of cell surface proteins, result in altered immunogenic properties of strains with compromised Efg1 function. This is
shown by interaction studies with macrophages and primary dendritic cells. The structural changes in the cell wall carbohydrate
meshwork presented here, together with the manifold changes in cell wall protein composition andmetabolism reported in
other studies, contribute to the altered immune response mounted by innate immune cells and to the altered virulence pheno-
types observed for strains lacking EFG1.
Many fungal pathogens, including the most prevalent humanfungal pathogen, Candida albicans, have the ability to grow
with different morphologies, as budding yeast or as filamentous
invasive hyphae. The growthmode ofC. albicans is determined by
environmental conditions, including host factors. While yeast
growth is favored at low temperatures and high glucose concen-
trations, germ tubes leading to formation of hyphae occur in the
presence of various stimuli, including neutral pH, elevated CO2
levels, higher temperatures, and the presence of serum or
N-acetylglucosamine in the medium (2).
The transcription factor Efg1 was originally identified by its
ability to promote pseudohyphal growth in the nonpathogenic
yeast Saccharomyces cerevisiae. Efg1 is a member of the APSES
family of basic helix-loop-helix transcriptional regulators and is
one of the best-characterized regulators of hyphal morphogenesis
inC. albicans (52). Efg1 is a key regulator of virulence, and like the
related pseudohyphal activator Phd1 and repressor Sok2 in S.
cerevisiae, Efg1 is regulated by the Ras-cyclic AMP (cAMP)-
protein kinase A (PKA) pathway (49). Efg1 is also a key regulator
of filamentation in the presence of serum (28) and is involved in
the transcriptional response to it (31).Deletion ofEFG1negatively
affects filamentation under most conditions, but Efg1 acts as a
filamentation repressor under oxygen limitation conditions (9, 44).
In addition to regulating the yeast-to-hypha transition, Efg1
has been implicated in numerous functions going far beyond the
regulation ofmorphogenesis. For instance, Efg1 is required for the
generation of chlamydospores (48), the white cell-specific tran-
scriptional profile (50, 51), biofilm formation (38), regulation of
cell wall proteins (9, 20, 42, 47), regulation of oxidative/fermen-
tativemetabolism (9, 20), heat stress resistance (20), and virulence
(28).
Efg1 is pivotal in sensing and transmitting host signals through
the cAMP-PKA signaling pathway to control chromatinmodifiers
such as the histone deacetylase Set3, which in turn is required for
virulence (22). Interestingly, Efg1 acts as both a positive and neg-
ative regulator for different sets of target genes, and one-hybrid
experiments showed that Efg1 acts primarily as a transcriptional
repressor (20, 32). Numerous transcriptional profiling data dem-
onstrate that hypha-induced genes are coregulated with genes en-
coding known virulence factors, including proteases and ad-
hesins. Efg1 is directly involved in regulation of many of these
genes, including SAP4, SAP5, SAP6, ALS1, ALS3, HWP1, RBT1,
RBT4, ECE1, andmany others (9, 16, 20, 43, 46, 47). The observed
virulence defects after deletion of EFG1 could be connected di-
rectly to the changed expression of cell surface proteins, such as
adhesins and other virulence factors, under the control of this
transcription factor (47). For example, Als3 has been shown to be
crucial for binding and endocytosis of C. albicans by epithelia and
endothelia (35).
In contrast to the congenic clinical isolate SC5314, C. albicans
lacking Efg1 has strongly impaired adhesion and penetration of in
vitro tissue models (8). This strain also displays reduced endocy-
tosis and transmigration through epithelial (33, 53) or endothelial
(34, 35) cells. In addition, EFG1 null mutant cells have a lower
capacity to adhere to several extracellular matrices, such as fibrin-
ogen, fibronectin, tenascin, and laminin (42). This reduced ability
to adhere to and penetrate into tissue may also result in a signifi-
cantly delayed expression of human -defensins in reconstituted
human oral epithelia (30).
When efg1/efg1 cells encounter blood, lower survival rates than
those seen for the wild type (WT) are observed (13). In addition,
endocytosis and killing of the efg1/efg1 strain by polymorphonu-
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clear neutrophils (PMNs) ex vivo occur at a higher efficiency than
that for the wild-type strain. Moreover, this fungal strain causes
less damage to PMNs when endocytosed (24).
Notably, loss of EFG1 in C. albicans also strongly attenuates its
virulence in a mouse model of systemic infection, and in combi-
nation with deletion of an additional transcription factor, Cph1,
virulence is almost completely abolished (28). This effect has also
been shown in other virulence models, such as the murine cornea
(23), Caenorhabditis elegans (37), and Drosophila melanogaster
(5), confirming severe changes in the pathophysiology of C. albi-
cans in the absence of Efg1.
The fungal cell surface provides the primary contact point be-
tween the pathogen and the host, especially the host’s innate im-
mune system. As reported previously (9, 20, 47), lack of the tran-
scription factor Efg1 leads to dramatic changes in expression of
cell wall proteins such as cell wall synthesis and remodeling en-
zymes, including the chitinases encoded by CHT1-3, the chitin
synthases encoded byCHS1-5, the-1,3-glucan synthase subunits
encoded by FKS1, GSL21, GSC1, and KRE62, the -1,4-glucan
branching enzyme encoded byGLC3, the-1,6-glucan biosynthe-
sis enzymes encoded by KRE1 and SKN1, the glycosylhydrolase
encoded by CRH11, the glycosidases encoded by PHR1 and
SUN41, the 1,3--glucanosyltransferase encoded by PGA4, the
exo-1,3--glucosidase encoded by EXG2, the mannosyltrans-
ferase encoded by ECM39, and the structural protein encoded by
PIR1. In general, most of these genes are downregulated in efg1/
efg1 cells compared to the wild type, with the strongest effect in
hypha-inducing media such as alpha minimal essential medium
(-MEM) at 37°C.Nevertheless, Efg1p also has a strong impact on
gene expression in yeast extract-peptone-dextrose (YPD) me-
dium in the absence of filamentation stimuli (9, 20, 47).
The impact of these transcriptional changes on cell wall struc-
ture or polysaccharide composition in the efg1/efg1 mutant has
not been reported to date. In this report, we show that the tran-
scription factor Efg1 strongly impacts cell wall thickness as well as
its polysaccharide composition even if only one copy of the EFG1
gene is removed. Togetherwith the filamentation defects, thismay
explain the difference in efg1/efg1 strain virulence and its impaired
contact with effector cells of the innate immune system.
This new finding, in combination with other phenotypes ob-
served previously, helps to explain the severe changes in patho-
physiology of C. albicans devoid of EFG1, including the strongly
altered interaction with epithelial or immune cells and reduced
virulence, using mouse models of systemic infection.
MATERIALS AND METHODS
Strains and growth conditions. The C. albicans strains used in this study
are listed in Table 1. For experiments, cells were grown to exponential
phase (optical density at 600 nm [OD600] of 1.0) or post-exponential
phase (OD600 of 10) and cultured in rotary shakers at 30°C in YPD
medium (1% yeast extract, 2% Bacto peptone, 2% glucose).
Reintroduction of EFG1 into a heterozygous strain. A second func-
tional allele of EFG1 was reintroduced into the heterozygous strain
HLC17 in order to complement EFG1 haploinsufficiency. Genome exci-
sion of the URA3 cassette in strain HLC17 was induced on SC medium
containing 1mg/ml 5-fluoroorotic acid. Selected Ura strains were tested
for absence of the URA3 gene by PCR (with oligonucleotides URA3_F
[5=-GACCTATAGTGAGAGAGCAG-3=] and URA3_R [5=-TCTTGTCC
ACCCATATCACG-3=]) and further transformed with PacI-linearized
plasmid pTD38-HA (32), carrying a functional EFG1 allele. Positive Ura
transformants were selected on SC agar plates without uridine. Their
genomicDNAswere isolated, and Southern blotting was performed using
the restriction enzymeBglII. By probingwith anEFG1open reading frame
(ORF) probe (PCR product obtained using oligonucleotides EFG1_F1
[5=-CCCCCATACCTTCCAATTCT-3=] and EFG1_R1 [5=-GAGGAGCC
GAAGCAGAAGT-3=]), integration of the second functional EFG1 allele
into the originally disrupted EFG1 locus was confirmed, thus creating
HLC17Rev, containing two functional EFG1 alleles in their original loci.
URA3 complementation of strain CAI4. The HindIII-restricted (for
excision of the lacZ gene) and self-ligated plasmid pAU36RP10_KKf was
used forURA3 complementation of strain CAI4. This plasmid was previ-
ously prepared by M. Röhm by alteration of pCaEXP (4), in which the
MET3 promoter was replaced with the actin promoter (ACT1p) followed
by the lacZ gene and the actin terminator (ACT1t). On both sides of the
lacZ gene, HindIII sites were present and served for lacZ excision.
EFG1 transcript level determination. mRNAs from exponential-
phase and post-exponential-phase YPD-grown yeast cells were isolated
using an RNeasyminikit (Qiagen). Cells were disrupted by vortexing with
glass beads. One microgram of mRNA was transcribed into cDNA by
using a Verso cDNA synthesis kit (Thermo Scientific) following the tech-
nical bulletin of the producer. Quantitative reverse transcription-PCR
(qRT-PCR) quantification of gene expression was performed in duplicate
or triplicate in a LightCycler 480 instrument (Applied Biosystems), using
Maxima SYBR green qPCR master mix (Fermentas) and the oligonucle-
otides listed in Table 2. For analysis of the data, Livak’s CT method was
used (27), and expression levels of Efg1 were normalized to the 18S rRNA
transcript level. Results for a representative experiment based on two bi-
TABLE 1 C. albicans strains used for this study
Strain Genotype Reference
SC5314 Wild type 19
CAI4 ura3::1 imm434/ura3::1 imm434 11
CAI4 URA3 ura3::1 imm434/ura3::1 imm434 RP10::URA3/RP10 This work
HLC17 ura3::1 imm434/ura3::1 imm434
EFG1/efg1::hisG-URA3-hisG
28
HLC17Rev ura3::1 imm434/ura3::1 imm434
EFG1/efg1::[EFG1p-HA-EFG1-URA3]
This work
HLC52 ura3::1 imm434/ura3::1 imm434
efg1::hisG/efg1::hisG-URA3-hisG
28
HLC74 ura3::1 imm434/ura3::1 imm434 efg1::hisG/efg1::
hisG (EFG1)
28
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ological replicates are presented, with standard deviations based on qRT-
PCR triplicates.
Agar plate drop tests. Drop tests were performed to test the growth
phenotypes of Candida strains in the presence of various compounds.
Yeast nitrogen base (YNB) plates containing sublethal doses of cell wall-
disturbing agents were used. Agar plates without additives served as con-
trols. In a 96-well plate, 1:10 dilution series of strains starting from an
OD600 of 1.0 were prepared with sterile distilled water (dH2O). Dilution
series of strains were transferred from 96-well plates to agar plates by use
of a 48-replica plater (Sigma-Aldrich), transferring about 4 l of the sus-
pension. Agar plates were incubated at 30°C for 2 days and documented
by photography.
Zymolyase treatment. Cell wall Zymolyase 100T (Seikagaku) treat-
ment was performed to investigate changes in cell wall sensitivity to the
-1,3-glucan laminarinpentaohydrolase fromArthrobacter luteus. The ex-
periment was performed in 1.5-ml plastic cuvettes. YPD-grown
exponential-phase or post-exponential-phase cells were pelleted, washed
with dH2O, and resuspended in dH2O to an OD600 of 3.0. Approximately
400-l aliquots of cell suspension of each strain were added to the cu-
vettes, together with 400 l of 150 mM Tris-HCl, pH 7.5, containing 180
mM beta-mercaptoethanol (-ME), and were incubated for 5 min at
room temperature. Prior to measurement, 400 l of Zymolyase 100T
(concentration of 1.8 g/ml [0.18 U/ml] for exponential-phase cells
and concentration of 30 g/ml [3 U/ml] for post-exponential-phase
cells [OD,10]) in dH2Owas added; theOD600 in cuvettes was read every
5 min over a 1-h period. The content of the cuvettes was resuspended by
vortex mixing prior to each measurement.
Electron microscopy. Two milliliters of exponentially growing Can-
dida cells in YPD (OD600, 1.0) was fixed for 1 h at 4°C with 2.5% glu-
taraldehyde. After fixation, cells were washed three times for 15 min each
with 1 ml of fresh YPD. After the last wash, 0.5 ml 2% KMnO4 in dH2O
was added to the cells and incubated at room temperature for 90 min.
Cells werewashed three timeswith 1ml dH2Oand then slowly dehydrated
by incubation with 1 ml each of 30%, 50%, 70%, 90%, and 100% acetone
for 15 min each, with centrifugation after each step (1 min, 2,000  g).
Finally, cells were washed twice in absolute acetone and incubated for 1 h
in a mixture of 1/3 Spurr’s medium-hard resin (Polysciences) and 2/3
acetone in a closed Eppendorf tube. Tubes were then opened, and the
acetone was evaporated overnight at room temperature. The cells were
incubated twice for 1 h with fresh Spurr’s resin, overlaid by the resin in
5.6-mm Beem capsules, and baked at 65°C for 48 h. After trimming with
a razor blade, samples were sectioned with glass knives to 70-nm sections
(Ultramicrotom; Leica Ultracut) and collected on a water surface. Sec-
tionswere transferred to the surface ofmesh grids coveredwith Pioloform
support film and stained for 6min in 1%uranyl acetate and, after washing
with dH2O for an additional 4 min, in 1% lead citrate. Washed and dried
samples were examined and documented using an electron microscope
(FEI Tecnai G2 microscope equipped with a Tietz F224 digital camera).
Multiple cells of each strain were imaged. The average cell wall thickness,
from themembrane to themiddle of the electron-dense outermannopro-
tein layer, was measured manually for at least 20 individual yeast cells.
Cell wall isolation and determination of polysaccharide composi-
tion. Briefly, 50 to 100 ml of exponential-phase or post-exponential-
phase cells in YPD medium was washed twice with dH2O. Cells were
resuspended in 1 ml of 10 mM Tris-HCl, pH 7.5, and kept on ice. To the
suspension, 300 l of glass beads was added (0.25- to 0.5-mm diameter;
Roth), and the sample was intensively vortexmixed at 4°C for 30min. The
disrupted cell suspension was recovered and washed twice with 1 ml of
dH2O. Cell walls were extracted three times at 100°C with 1 ml of extrac-
tion buffer (50 mM Tris-HCl, pH 7.8, 2% SDS, 10 mM EDTA, 40 mM
-mercaptoethanol). The pellet was washed five times with 1 ml dH2O,
frozen, and then lyophilized.
The hydrolysis protocol was modified from a previously described
method (14). About 10 mg of lyophilized cell walls was incubated in
1.5-ml Eppendorf tubes with 75 l of 72% H2SO4 for 3 h at room tem-
perature. After 3 h, 950 l of dH2O containing 1 mg/ml galactose was
added as an internal control. Reaction tubes were incubated for another 4
h at 100°C. The mixtures were then transferred to 15-ml Falcon tubes.
Reaction tubeswere rinsed twicewith 1ml dH2O, and this was collected in
the Falcon tubes as well. The acid solutionwas neutralizedwith about 4ml
of saturated Ba(OH)2 water solution (approximately 40 g/liter). The pre-
cipitate was left to be formed overnight at 4°C. The pH was then adjusted
to between 6.0 and 8.0 [with H2SO4 and Ba(OH)2], and the final volume
was adjusted to 10ml with dH2O. The formed precipitate was centrifuged
and discarded. Finally, the sugar content was determined by high-
performance ion chromatography (HPIC) measurement (using glucosa-
mine for chitin, glucose for -1,3- and -1,6-glucans, mannose for man-
nans, and galactose as an internal control), using standard dilutions for
calibration.
To determine the absolute amount of glucose relative to cell biomass,
50 ml of exponential-phase or post-exponential-phase cells in YPD me-
diumwas pelleted andwashed twice with dH2O. The cell pellet was frozen
and lyophilized. Approximately 10-mg specimens (the exact weight was
recorded) of lyophilized cells were resuspended in 1.5-ml Eppendorf
tubes in 75l of dH2O. Additionally, 75l of 72%H2SO4 was added, and
the samples were incubated for 3 h at 60°C. After 3 h, 850l of dH2O was
added, and reaction tubes were transferred for another 4 h to a heating
block set at 100°C. After hydrolysis, the glucose concentration was deter-
mined using an enzyme-coupled reaction (29). The total amount of glu-
cose was related to the biomass used for hydrolysis. This enzymatic reac-
tion has a high specificity for glucose and is unaffected by other
monosaccharides.
For measurements of intracellular glucose units, about 10 mg of dry
cell biomass was disrupted in 1 ml of dH2O with 300 l glass beads by
vortex mixing at 4°C for 30 min. To hydrate all of the polysaccharides,
samples were incubated at 100°C for 15 min and then shortly vortex
mixed. The glass beads and the solid parts of the cells were spun down. To
500l of the suspension, 50l of 72%H2SO4 was added, and the suspen-
sion was incubated at 100°C for 6 h. After hydrolysis, glucose concentra-
tions were measured as described above, and concentrations were related
to the cell biomass used for glass bead disruption.
-1,3-Glucan staining and analysis.Approximately 1 108Candida
cells were fixed for 5 min in 3.7% formaldehyde, washed with phosphate-
buffered saline (PBS), and blocked for 1 h with 1 ml PBS plus 2% bovine
serum albumin (BSA) at room temperature with rotation. Cells were
stained with mouse anti--1,3-glucan primary antibody (100 l [1:100]
in PBS plus 2% BSA; original antibody concentration, 1 mg/ml; Biosup-
plies) for 1 h with rotation at room temperature. Cells were washed four
times with 1 ml of PBS. Secondary antibody staining was performed for 1
h with rotation at room temperature with Alexa 488-conjugated goat
anti-mouse antibody (1:100 in 100 l PBS plus 2% BSA; Invitrogen).
During this step, samples were protected from light. Cells were washed 4
times with 1 ml PBS. Unstained cells and cells stained only with the sec-
ondary antibody were used as negative controls. Cells were examined
microscopically using an Axiovert 200 M microscope (Zeiss) with an ap-
propriate fluorescence filter and a constant exposition time for all sam-
ples. Pictures were further processed using Adobe Photoshop, keeping the
original size ratio and color intensity. The intensity of the fluorescence
signal was measured with Aida software, using one-dimensional densi-
tometry. Fluorescence intensity and particle size were additionally quan-
tified using a Beckman Coulter Epics XL/MCL flow cytometer with exci-
tation at 488 nm and emission at 525  10 nm. Collected data were
analyzed using FlowJo software. Intensities and cell sizes are presented as
averages for three biological replicates, with standard deviations.
Reactive oxygen species (ROS) assay using the RAW264.7 macro-
phage cell line. The murine macrophage RAW264.7 cell line (ATCC TIB-
71) (39) was grown in supplemented Dulbecco’s modified Eagle’s medium
(DMEM; 10% fetal calf serum [FCS], 0.075% NaHCO3, 1 mM sodium py-
ruvate, 0.1mg/ml gentamicin) at 37°Cwith 5%CO2.Whengrown to conflu-
ence, macrophages were detached from the 75-cm2 cell culture flask
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(Greiner) byusing trypsin-EDTA(Gibco). For chemiluminescence assay, the
RAW264.7 cells were harvested using a cell scraper, further resuspended in
HEPES-buffered BSA (10 mM HEPES, pH 7.3, 5.5 mM glucose, 1 mM
MgCl2, 5mMKCl, 145mMNaCl, 4mMNaHCO3, 1mMCaCl2, 0.1%BSA,
pH7.3), anddiluted to 2 106 cells/ml. From this suspension, 50l (1 105
cells) per well was added to a white 96-well plate (Nunc). After incubation at
37°C and 5% CO2 in the dark for about 30 min, 100 l of HEPES-buffered
BSA containing 0.2 mM luminol (Sigma) and 40 U/ml horseradish peroxi-
dase (HRP) typeVI (Sigma)was added.Prior tomeasurement, either 50l of
HEPES-buffered BSA containing unopsonized zymosan (100g/ml; Sigma)
or 5 105 Candida cells (1 107 cells/ml) were added to the wells. HEPES-
buffered BSA served as a negative control. The well content was mixed thor-
oughly. Chemiluminescence emitted from each well was immediately re-
corded in the dark at 37°C for 120min at 2.5-min intervals in a 96-well plate
reader (Synergy 2; BioTek). Luminescence is given in relative luminescence
units (RLU) s1.
Interaction of Candida cells with mDCs. Bone marrow-derived mu-
rine (from7- to 9-week-oldC57BL/6wild-typemice)myeloid dendritic cells
(mDCs) were obtained exactly as described earlier (15), and differentiated
cells were plated in 30-mm plates (1 106 mDCs/dish; 3 ml). The next day,
cells from exponentially growing Candida cultures (in YPD) were pelleted
and resuspended in PBS. After estimations of cell counts, dendritic cells were
infected with 100 l of Candida cell suspension (2 107 cells/ml) at a mul-
tiplicity of infection (MOI) of 2:1 (Candida cells:mDCs) and were incubated
at 37°Cand5%CO2.After 4hof incubation,plateswereplacedon ice and the
mediumwas aspirated (except for the negative control, where mDCs in me-
dium were nonadhered). The medium from negative controls was centri-
fuged, and175l ofRNA lysis buffer (Promega) containing-MEwas added
to the pellet. To the infected plates, 175l of the same buffer was added, and
mDCs were scraped off the plates. Samples were placed on filter columns
(Macherey-Nagel), and DNA was sheared by centrifugation. Supernatants
from the flowthrough were collected, and RNA was extracted using an SV
total RNA isolation system (Promega) according to the manufacturer’s in-
structions. About 1g of RNAwas transcribed into cDNAby using a reverse
transcription system (Promega) following the technical bulletin of the pro-
ducer. qRT-PCR quantification of gene expression was performed in aMas-
tercycler EP Realplex system (Eppendorf), using Mesa green qPCR Master-
Mix Plus for SYBR green assay (Eurogentec), alongwith the oligonucleotides
listed in Table 2. For analysis of the data, Livak’sCTmethod was used (27),
and expression levels of cytokines were normalized to the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) transcript level. Results for a represen-
tative experiment based on two biological replicates are presented, with stan-
dard deviations based on qRT-PCR triplicates.
RESULTS
Deletion of EFG1 affects structural components in the C. albi-
cans cell wall. Efg1 is a central regulator of gene expression, includ-
ing that of genes that encode cellwall remodeling enzymes (9, 20, 47).
However, until now, consequences of EFG1 deletion on cell wall
structures have not been described, and only a few biochemical data
are available concerning changes in protein and carbohydrate com-
position. Previous experiments showed that a strain lacking EFG1 is
hypersensitive to calcofluorwhite (20),which acts on the chitin layer,
indicating impaired cell wall biogenesis. In contrast, Congo red is
considered to act on the cell wall glucan structure (21, 40). In agar
plate assays, an efg1/efg1 null mutant (HLC52) showed a high sensi-
tivity to Congo red which was restored to WT levels in a revertant
strain harboring a restored functional allele of EFG1 (HLC74) (Fig.
1A). This result indicates that the glucan structure in an EFG1 dele-
tion strain is also perturbed.
To further confirm the apparent cell wall defects, we incubated
exponentially growing cells of SC5314 andHLC52 (efg1/efg1) with
Zymolyase 100T. Zymolyase hydrolyzes-1,3-glucan and thereby
destroys the cell wall. Thus, the kinetics of Zymolyase digestion
may reflect changes in cell wall structure, predominantly in its
glucan component. By analyzing exponentially growing cells, no
statistically significant differences between the wild type and the
HLC52 efg1/efg1 null mutant were detectable (Fig. 1C), consistent
with previous work (20). Using cells frompost-exponential-phase
cultures (OD, 10), however, we observed a significantly in-
creased sensitivity of the EFG1 deletion strain (HLC52) compared
to the wild type (Fig. 1B). For the EFG1-reconstituted strain
(HLC74), we observed only a partial reversion of the phenotype to
one somewhere between those of the wild type and the null mu-
tant, indicating an EFG1 gene dosage effect. Similar kinetics of
degradation were observed for the efg1/EFG1 heterozygous strain
(HLC17). Reversion of the heterozygote by reintegration of a sec-
ond functional EFG1 allele (HLC17Rev) at the genomic EFG1
locus resulted in full reversion of the phenotype and in kinetics of
degradation identical to those of wild-type strain SC5314, con-
firming the observed gene dosage effect for EFG1. In addition,
FIG1 (A)Drop tests for sensitivity to the cell wall-disturbing agent Congo red
(CR). Plates were cultivated at 30°C and documented after 2 days. The sensi-
tivities of post-exponential-phase (B) and exponentially growing (C) cells to
Zymolyase 100T are shown. Data represent averages for three independent
experiments.
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strain CAI4 URA3, a newly preparedURA3 revertant of the ura3/
ura3 auxotrophic strain CAI4 (11), was included in the assay in
order to exclude a URA3 positioning effect. As expected, this
strain displayed cell wall properties similar to those of wild-type
strain SC5314 in this assay.
These data show that deletion of the EFG1 gene not only has a
prominent effect on the cell wall protein composition, as reported
previously (47), but most likely also has an effect on the polysac-
charide matrix. Interestingly, the stronger effect in aging cells im-
plies a crucial role of Efg1 in cell wall homeostasis during post-
exponential-phase growth.
Transcriptional analysis of EFG1 mRNA levels. In order to
verify if the gene copy number is actually reflected in the transcript
level of EFG1, its mRNA levels in exponential-phase and post-
exponential-phase strains were measured using quantitative real-
time PCR (Fig. 2). 18S rRNAwas used for normalization, since the
expression levels of two other genes tested for this purpose (ACT1
and TDH3) were affected by the different conditions used
(exponential-phase versus post-exponential-phase growth). In
total, three biological replicates were performed. We observed a
measurable degree of variation among the three biological repli-
cates, most likely due to the low level of EFG1 transcripts. Never-
theless, for all experiments, we saw no EFG1 transcript for the
HLC52 deletion mutant and significantly lower transcript levels
for the HLC74 revertant, not reaching the levels in the heterozy-
gote strain HLC17, during both exponential- and post-
exponential-phase growth. The heterozygote (HLC17) and het-
erozygote revertant (HLC17Rev) strain displayed the most
variation. However, as shown in Fig. 2, especially for post-
exponential-phase cells, EFG1 transcript levels in general were
higher in HLC17Rev than in SC5314, whereas they were lower in
HLC17. In exponentially growing cells, only HLC74 showed con-
sistently lower levels of EFG1 transcript than theWT, whereas the
measurements in the other strains did not reveal significant dif-
ferences within the error rate of the experiment. This confirmed,
at least for post-exponential-phase cells, a gene dose- and, to a
certain extent, allele-specific effect. An interesting additional re-
sult was the increase in EFG1 expression during post-exponential-
phase growth, which actually enabled detection of the differences
in the respective strains. This was also reflected in the differences
in Zymolyase sensitivity between exponential-phase and post-
exponential-phase cells, as described above.
Deletion of EFG1 affects cell wall polysaccharide composi-
tion and the internal carbohydrate pool. To analyze the impact
of EFG1 on the structure of the cell wall, we determined the cell
surface polysaccharide composition in strains with different copy
numbers of EFG1 expressed from two different genomic loci (Fig.
3). First, the total release of glucose units by acid hydrolysis of dry
cell biomass was determined for both exponential-phase and
post-exponential-phase strains, using an enzyme-coupled reac-
tion specific for glucose. The most abundant polysaccharides in
the cell wall are -1,3- and -1,6-glucans, which are converted
to glucose units. To account for glucose-containing carbohy-
drates present in the cytosol (mainly trehalose and glycogen),
cells were lysed by disruption with glass beads. After separation
of the cell wall fragments by centrifugation, the glucose con-
centration was determined following acid hydrolysis of total
cell extracts (Fig. 3A).
Although the copy number and position of the URA3 gene in
strain CAI4 URA3 did not seem to have any effect, deletion of
EFG1 had a significant effect on both glucose pools in the cell
(stored in the form of trehalose and glycogen) and the glucans of
the cell wall in exponential-phase and post-exponential-phase
cells. Determination of the entire amount of glucose released from
the different strains showed that deletion of EFG1 resulted in a
reduction of 33% compared to the WT level. For cell wall carbo-
hydrates, a reduction of 16% was determined, whereas internal
glucose pools were reduced by almost 60% in an efg1/efg1 null
mutant (HLC52). Reconstitution of one allele of EFG1 from the
LEU2 locus (HLC74) did not result in full reversion of this phe-
notype to the WT level. This is consistent with the phenotype of
the initial heterozygous strain (HLC17). The total, cell wall-
bound, and internal glucose pools were reduced by 14%, 10%, and
40%, respectively, for the heterozygote HLC17 and by 12%, 6%,
and 40%, respectively, for the revertant strain HLC74. However,
reintegration of a second allele of EFG1 in HLC17 (efg1/EFG1),
generating strain HLC17rev, which again contained two copies of
EFG1 at the original genomic loci, restored the levels of all glucose
pools analyzed toWT levels. No statistically significant differences
in glucose levels related to biomass (both cell wall related and
intracellular) were observed between exponential-phase and post-
exponential-phase cells in this case (Fig. 3A and data not shown).
These results indicate that deletion of even one EFG1 allele is
crucial for the level of intracellular, cell wall, and, consequently,
total glucose pools in C. albicans. Our results reflect a strong hap-
loinsufficiency phenotype of EFG1 for cell wall biogenesis and
maintenance of cellular glucose pools. The significant differences
in glucose and glucan contents in the strains investigated may be
explained by an altered metabolism, as reported previously for an
efg1/efg1 null mutant strain (9, 20). Deletion of EFG1 enhances
oxidativemetabolism, while genes required for glycolysis and glu-
FIG 2 Transcriptional analysis of EFG1. Levels of EFG1 mRNA transcripts
were determined for exponential-phase and post-exponential-phase cells of
strains carrying one or two copies of EFG1. Levels were normalized to the 18S
rRNA transcript level. In total, three biological replicates were performed, and
the results of a representative one are presented, with standard errors originat-
ing from qRT-PCR replicates. For each strain, mRNA levels were related to the
absolute level of EFG1 transcripts in exponentially growing wild-type SC5314,
which was set to 1.
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coneogenesis are repressed. This is expected to result in reduced
glucose pools in the cell.
In addition to the ratio of glucan-bound glucose units to the
dry cell biomass, the ratios of glucose (glucans), glucosamine (chi-
tin), and mannose (mannosylated proteins) were determined by
HPIC after acid hydrolysis of purified cell walls. Their relative
amounts are listed inTable 3. By correlating the proportions of the
individual sugars to the absolute amount of cell wall glucose re-
lated to the dry cell biomass, we were able to determine the abso-
lute amounts of the individual cell wall components. Using this
approach, we could determine which components in the cell wall
remained constant and which components changed (Fig. 3B). As
shown in Fig. 3A, the decrease of glucan levels of about 16% in the
efg1/efg1 strain (HLC52) was close to the number for the strains
containing only one EFG1 allele, while strain CAI4 URA3 was
consistent in cell wall composition with wild-type strain SC5314,
excluding a position effect ofURA3 as the cause for this result. On
the other hand, we could not detect significant differences in the
chitin levels of all strains tested. Although the mannan levels did
show differences among the strains, no significance with regard to
the copy number of EFG1 could be observed. This indicates that
EFG1 has its strongest impact on the biosynthesis of the glucan
meshwork and seems to have only a minor impact on chitin bio-
synthesis. The total amount of cell wall polysaccharide compo-
nents for the wild-type strain SC5314 was determined to be 21.4%
of the total cell mass in exponentially growing cells. This is in
agreement with previous findings showing that the cell wall mass
represents about one-fifth of the total cell biomass and validates
the general proceedings of these experiments. Again, post-
exponential-phase cells showed no significant changes in relative
cell wall composition compared to exponentially growing cells
(data not shown).
Deletion of EFG1 reduces cell wall thickness. The total
amount of cell wall polysaccharides was reduced by about 20% in
HLC52 compared to the wild-type strain SC5314. This should
have a severe impact on the cell wall thickness and/or structure. To
investigate changes in the physical dimensions, we analyzed cell
wall morphology by using transmission electron microscopy. In-
terestingly, the average thickness of the cell wall of the efg1/efg1
strain (HLC52) was reduced to only 57% of the width of the wild-
type cell wall (Fig. 4). The average thickness of the SC5314 cell wall
in electronmicroscopy images was 82.7 7.8 nm,while the thick-
ness of the efg1/efg1 cell wall was 47.1  6.8 nm. Although these
data are somewhat artificial due to cell fixation for electron mi-
croscopy and thusmay not directly reflect the in vivo situation, the
relative changes in cell wall thickness among strains allow them to
be comparedwith each other. In strains containing only one func-
tional allele of EFG1 (heterozygote strain HLC17 and revertant
strain HLC74), we observed an average reduction of about 15%
from the wild-type thickness, but individual cells of SC5314,
HLC17, andHLC74 showed overlapping cell wall thicknesses. Re-
introduction of the second allele into the heterozygous strain
(HLC17Rev) resulted in the same average cell wall thickness as
that of wild-type strain SC5314. On the other hand, in CAI4
URA3, the cell wall thickness remained unaltered from that of
wild-type strain SC5314. This further supports the hypothesis that
the cell wall effects are dependent on EFG1 rather than onURA3’s
position and copy number in the respective strains. These data are
FIG 3 Polysaccharide composition of the fungal cell wall. (A) Absolute amounts of glucose released by hydrolysis of total dry cell biomass and cytosolic contents
of exponentially growing strains SC5314,CAI4URA3,HLC17,HLC17Rev,HLC52, andHLC74. (B)Absolute polysaccharide cell wall compositions related to dry
cell biomass of exponentially growing strains. All of the data are based on three independent experiments, and average values with standard deviations are
presented.
TABLE 3 Relative cell wall compositions of different strains
Straina
% of component (mean SD)
Glucans Mannans Chitin
SC5314 (EFG1/EFG1) 71.0 2.5 23.5 2.6 5.5 0.1
CAI4 URA3 (EFG1/EFG1) 70.5 4.3 23.9 1.4 5.6 0.0
HLC17 (efg1/EFG1) 71.9 0.8 23.4 1.3 4.7 0.6
HLC17Rev (eE/EFG1) 74.1 0.8 20.1 0.8 4.9 0.2
HLC52 (efg1/efg1) 68.0 1.2 25.8 1.7 6.2 0.4
HLC74 (efg1/eE) 68.6 1.0 26.0 0.8 5.5 0.2
a eE, the efg1 allele was complemented with the EFG1 gene.
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also consistent with the reduced amounts of carbohydrates found
in strains lacking at least one copy of the EFG1 gene. This addi-
tionally supports our results showing that deletion of one EFG1
gene copy in theC. albicans genome already has a prominent effect
on the cell wall structure, most likely due to reduced glucose pools
in such strains. Apart from the-glucan layer thickness, all strains
had similar cell wall architectures, consisting of an electron-dense
outer layer, assigned to mannoproteins, and an electron-lucent
inner layer, assigned to -glucans and chitin.
EFG1 affects-1,3-glucan exposure.To check if the structural
changes in the cell wall also have consequences on -glucan expo-
sure, which is considered a critical virulence factor in C. albicans
(54), we visualized -glucan in exponentially growing cells of the
respective strains (SC5314, CAI4 URA3, HLC17, HLC17Rev,
HLC52, and HLC74) by using a -1,3-glucan-specific antibody
(Fig. 5A). Interestingly, immunodecoration of these strains indi-
cated a clear difference already after deletion of one EFG1 allele
compared to the WT. When the data were quantified by
fluorescence-activated cell sorter (FACS) analysis (Fig. 5B),
exponential-phase and post-exponential-phase cells of strains
HLC17, HLC17Rev, HLC52, and HLC74 displayed significantly
higher signals, with at least 2-fold increases in intensity, than the
wild type. However, strainHLC52, with both EFG1 alleles deleted,
showed a slightly smaller increase in -1,3-glucan exposure than
strains HLC17, HLC17Rev, and HLC74 (80% for exponential-
phase cells and 25% for post-exponential-phase cells). TheURA3-
complemented CAI4 strain displayed fluorescence signal
intensities comparable to those of the wild type. In general, post-
exponential-phase cells attracted significantly smaller amounts of
bound -1,3-glucan antibodies, but we observed similar relation-
ships between the strains analyzed to those for exponentially
grown cells (Fig. 5B).
Interactionwithmacrophages and ROS release.The produc-
tion of ROS by innate immune cells is part of the first line of
defense against pathogens (6, 12). ROS assays can thus be used to
evaluate recognition of microbes by the immune system (18). Al-
though the molecular identities of ligands triggering the ROS re-
sponse are not fully characterized, the main candidates include
-1,3- and -1,6-glucans (17, 41). The changed -1,3-glucan ex-
posure and general changes in cell wall architecture in the efg1/efg1
strain (HLC52) implied a high probability of altered immunolog-
ical properties of HLC52. Therefore, we employed the murine
macrophage cell line RAW264.7 to analyze the release of ROS
during contact with our fungal strains (Fig. 6). Zymosan, a crude
cell wall preparation from Saccharomyces cerevisiae, served as a
positive control for triggering the ROS response. In the assay, we
employed exponential-phase (OD600,1) and post-exponential-
phase (OD600,10) cells to check the immunogenic properties of
fungal strains in distinct growth phases.
For SC5314 and CAI4 URA3, we observed rapidly induced
ROS levels upon incubation with macrophages (Fig. 6A and B).
Most interestingly, the growth phase of both strains stronglymod-
ulated the intensity of ROS release of macrophages. Post-
exponential-phase cells showed 6- to 7-fold-increased ROS levels
compared to exponentially growing cells, although the ROS re-
lease was slightly delayed. Exponentially growing efg1/efg1 cells
also triggered significant ROS release, with a short delay in induc-
tion similar to the delay for post-exponential-phase SC5314 or
CAI4 URA3 cells. When exponentially growing strains with one
functional EFG1 copy (heterozygote strain HLC17 and revertant
FIG 4 Cell wall thicknesses and representative transmission electronmicroscopy images. (A) Cell wall thicknesses were estimated from over 20 independent cell
measurements obtained from different microscopic images. Representative images of the cell walls of wild-type strain SC5314 (B) and the efg1/efg1 mutant
HLC52 (C) present differences in thickness of the electron-translucent polysaccharide layer. Images were taken at a magnification of 20,000 and represent
identical areas.
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strainHLC74)were examined, they showed the samedelay inROS
release as the efg1/efg1 strain (HLC52). ROS levels exceeded the
WT level by 30% to 60% but were in the range of the CAI4 URA3
levels. HLC17Rev, containing two copies of EFG1, also displayed
anROS response under these conditions, with the same kinetics as
the wild type, although at up to 2-fold higher levels (up to 1.5-fold
higher than CAI4 URA3 levels). CAI4 URA3 displayed similar
kinetics to wild-type strain SC5314 andHLC17Rev, both contain-
ing two EFG1 copies, with intensities between those of SC5314
and HLC17Rev.
During post-exponential-phase growth, SC5314, CAI4 URA3,
and HLC17Rev showed highly similar ROS responses, both in
strength and in the time point of induction. However, under these
conditions, a severe reduction in ROS response in strains lacking
one or two copies of EFG1was apparent, by a factor of 10 ormore.
In fact, the ROS levels in these strains remainedmore or less at the
levels in exponentially growing strains. Thus, we did not see an
FIG 5 -1,3-Glucan antibody staining of the cell surface. (A) Exponentially
growing and -1,3-glucan antibody-labeled strains were examined under a
microscope. All figures represent equal areas. Fluorescent images were taken
with a constant exposition time to compare signal intensities. For control
samples labeled only with secondary antibodies, no visible fluorescence was
detectable (not shown). (B) Labeled -1,3-glucan in exponential-phase and
post-exponential-phase cells was quantified by FACS analysis. Intensity medi-
ans for three biological replicates were combined and supplementedwith stan-
dard errors. Fluorescence intensity was normalized to that of exponentially
grown wild-type SC5314, which was set to 1.
FIG 6 ROS release by macrophages challenged with strains SC5314, CAI4
URA3, HLC17, HLC17Rev, HLC52, and HLC74 in exponential-phase (A) or
post-exponential-phase (B) growth. Data were reproduced in three indepen-
dent experiments performed in quadruplicate. Average results for representa-
tive experiments are presented. Standard deviations for individual time points
were within 10% of absolute values.
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increase in ROS release in these strains due to the growth phase of
the cell, like that shown for the WT, indicating that EFG1 plays a
central role in growth-phase-dependent cell wall biogenesis.
These data confirm that deletion of one EFG1 allele in C. albi-
cans already causes significant changes in its immunological prop-
erties during confrontation with macrophages. Deletion of the
second EFG1 allele pronounces this effect further. This demon-
strates the importance of Efg1 for C. albicans cell wall biogenesis
and maturation in post-exponential-phase growth. Interestingly,
the higher -1,3-glucan exposure in the efg1/efg1 strain (HLC52)
did not result in an increased ability to stimulate the ROS re-
sponse, indicating that there are additional factors relevant to the
ROS response in these strains.We also observed an increase in the
macrophage ROS response to post-exponential-phase wild-type
cells, although according to our results shown above, they expose
less -1,3-glucan in this growth phase.
Transcriptional response of mDCs to C. albicans deleted for
EFG1. We performed qRT-PCR analysis to check the cytokine
immune response of primary mDCs to the different EFG1 strains
(Fig. 7). As typical antigen-presenting cells, mDCs in general offer
a faster and stronger response to Candida cells than that of mac-
rophages. Moreover, antigen-presenting dendritic cells, usually
residing onmucosal surfaces and in the skin, play important roles
in anti-Candida protective immunity. Dendritic cells function as
professional phagocytes to kill C. albicans, modulate the immune
response, and subsequently present antigens to adaptive immune
cells. In addition, defined sets of cytokines, depending on the
phagocytosed pathogen, are released to direct the following im-
mune responses. We analyzed the mRNA levels of a set of cyto-
kines indicative of Th1, Th2, and Th17 responses in order to re-
ceive a first indication about potential changes in the immune
response. Compared to thewild type, deletion of one or two copies
of EFG1 resulted in reduced expression of several cytokines, such
as tumor necrosis factor alpha (TNF-), interleukin-4 (IL-4), IL-
23, and, to a minor extent, IL-1. Reversion of both alleles
(HLC17rev) resulted in WT levels or slightly higher levels. The
lower cytokine response is consistent with the reduced capacity of
the efg1/efg1 null mutant to stimulate the ROS response in mac-
rophages. In the previous experiments, we did not identify signif-
icant differences between the two strains that are heterozygous for
EFG1, i.e., HLC17 (a heterozygote containing oneWT allele at the
original locus) andHLC74 (a revertant containing oneEFG1 allele
expressed from the LEU2 locus). However, the levels of TNF-,
IL-4, and IL-23 transcripts in response to HLC17 and HLC74
showed clear differences. While the HLC17 response in general
resembled that of the WT, the HLC74 response resembled that of
the efg1/efg1 null mutant. This may indicate additional subtle ef-
fects due to the different chromosomal locations of EFG1 in these
strains, as also suggested by the differences in EFG1 expression
levels (Fig. 2). For additional cytokines tested (IL-10 and IL-12),
FIG7 Transcriptional responsesofunstimulatedmDCsandmDCs incontactwith theSC5314wild-type,CAI4URA3revertant, andEFG1mutant strains.mRNAlevels
were related to the absolute level of mDCs treated with wild-type SC5314, which was set to 1. Determinations were performed in triplicate, and average values with
standard deviations are presented. Results are representative of two independent experiments. In the presence of wild-type strain SC5314, the level of IL-4 was induced
by 1 order of magnitude, while the rest of the studied cytokines were induced by 2 orders of magnitude, compared to the basal levels in unstimulatedmDCs.
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loss of EFG1 did not result in a reduction of cytokine levels. On the
other hand, when strain CAI4 URA3 was assayed, in general, no
differences in expression of the studied cytokines were observed
compared to the wild type. This again excludes the URA3 gene
from the observed changes in the cell wall resulting in the altered
immunogenicity of the strains lacking EFG1. Our results indicate
that the changes in cell wall structure observed previously in the
efg1/efg1nullmutant, togetherwith changes in expression levels of
genes encoding cell wall proteins, contribute significantly to its
reduced immunogenic properties.
DISCUSSION
In this study, we investigated the impact of Efg1 on cell wall archi-
tecture and its ability to trigger the host response when the patho-
gen is in contact with immune cells.
We show that the cell wall polysaccharide structure of C. albi-
cans is significantly affected by the loss of individual genomic al-
leles of EFG1. The cell wall shows a clear reduction in size, both on
a morphological level and after biochemical analysis. Our results
strongly suggest that this is caused by a reduction of the amount of
glucan in the cell wall. This was confirmed by the increased sensi-
tivity to both Congo red and the cell wall-degrading enzyme Zy-
molyase, especially in post-exponential-phase cells. This pheno-
type can be rationalized by previous transcriptional data showing
altered regulation of genes required for cell wall biogenesis, in-
cluding a subset of genes encoding cell wall synthesis and remod-
eling enzymes. It could also be due to a shift toward an oxidative
metabolism, resulting in reduced glucose pools in the cell (9, 20, 47).
Most interestingly, EFG1 shows severe haploinsufficiency with
respect to certain cell wall-related phenotypes, indicating that the
level of Efg1 is critical for proper cell surface homeostasis. Al-
though EFG1 haploinsufficiency is not evident for growth on
Congo red, deletion of even a singleEFG1 allele impairsC. albicans
cell wall resistance to Zymolyase.Moreover, transmission electron
microscopy imaging showed a decrease in cell wall thickness after
deletion of EFG1, which is entirely consistent with the Zymolyase
hypersusceptibility. While the deletion of a single allele in both of
the efg1/EFG1 heterozygous strains reduced the average cell wall
thickness by about 15%, deletion of both alleles further reduced
the average cell wall thickness, to only 57% of the wild-type level.
Interestingly, mannan and chitin levels seemed to be less affected
than glucan levels. These data clearly indicate differences in the
structures of cell walls of strains expressing Efg1 at different levels.
Reintegration of a functional EFG1 allele into a null mutant and a
heterozygous strain restored the cell wall composition to hetero-
zygote and wild-type levels, respectively, confirming Efg1 as the
cause of these phenotypes. Measurements of EFG1 mRNA levels
in these strains by qRT-PCR confirmed the different expression
levels of EFG1, as expected, but due to the low expression levels,
these were more evident during post-exponential-phase growth.
In general, in this growth phase, EFG1 expression levels in
HLC17rev (expressingHA-EFG1 and theWT allele from the orig-
inal locus) were increased compared to those in the WT, whereas
both heterozygous strains showed reduced EFG1 mRNA levels.
No EFG1 expression was detectable in the HLC52 deletion strain.
The reduced cell wall thickness (57%) after deletion of both
EFG1 alleles was most likely caused by smaller amounts of
-glucans present in the cell walls (only 84%of theWT level). This
was observed for both exponential-phase and post-exponential-
phase cells. The observed difference between the reduction in cell
wall thickness (57% of the WT level) and the amount of glucan
(84% of the WT level) may be due to higher densities of glucan
fibers in the cell wall, which may support the stability of a weak-
ened scaffold. An additional explanation for this may be the fact
that efg1/efg1 cells are, on average, significantly smaller in volume
and thus have an altered cell surface-to-volume ratio (Table 4).
The effect of EFG1 deletion on cell morphology has already been
described (28, 52). Actually, the cell size of the efg1/efg1 null mu-
tant is further decreasedwhen cells go through the transition from
exponential-phase to post-exponential-phase growth. As deter-
mined by FACS analysis, the mean cell size of exponential-phase
and post-exponential-phase efg1/efg1 cells decreased to 84% and
68% (Table 4) that of SC5314, respectively, decreasing the spher-
ical surface ratio to 70% and 46%, respectively. This switch in cell
size provides an additional indication for the importance of Efg1
during different growth phases.
Besides the cell wall defects observed, deletion ofEFG1 strongly
reduces the levels of glucose units present in intracellular oligo-
and polysaccharides. This confirms for the first time, by direct
biochemical evidence, the predicted metabolic changes (based on
transcriptional profiling) toward increased oxidative metabolism
(9). The increased oxidation of carbohydrates and the reduction
of the gluconeogenesis pathway should result in reduced carbohy-
drate levels inside the cells.
In addition to the quantitative changes in theC. albicans cell wall,
we also detected larger amounts of -1,3-glucans accessible for anti-
body staining after deletion of EFG1 alleles. This was the only case in
which the revertedheterozygous strain (HLC17Rev)wasnot restored
to the wild-type level but showed a similar level of -1,3-glucan to
those of the heterozygousmutants, although the quantitative glucan-
to-biomass levels and macrophage responses (discussed below) be-
tween these two strains correlate. One explanationmight be that the
reintegrated EFG1-HA allele might not perfectly represent the WT
situation for all aspects of Efg1 action or that the detected increase in
EFG1mRNA in this strainmay be responsible for this effect aswell as
for other effects observed during these studies.
Changes in-glucan exposure often result in altered immunoge-
nicity. Indeed, we observed significant changes in the ROS response
of a murine macrophage cell line challenged with C. albicans strains
containing different EFG1 copy numbers. Interestingly, there ap-
peared to be a general difference in the ROS response depending on
the growth phase ofC. albicans. For SC5314 and CAI4URA3, a 6- to
7-fold stronger ROS response was observed in cells originating from
post-exponential-phase growth, but with a slight delay, possibly in-
dicating slower phagocytosis. This indicates that small differences in
growthphasemight alreadyhave a strong effect on theROSresponse.
TABLE 4 Relative cell sizes compared to exponential-phase SC5314
wild-type cells
Straina





SC5314 (EFG1/EFG1) 1.00 0.10 1.00 0.01
CAI4 URA3 (EFG1/EFG1) 1.02 0.24 0.92 0.08
HLC17 (efg1/EFG1) 1.05 0.03 0.79 0.06
HLC17Rev (eE/EFG1) 1.16 0.13 0.98 0.04
HLC52 (efg1/efg1) 0.84 0.10 0.68 0.04
HLC74 (efg1/eE) 1.08 0.14 1.08 0.05
a eE, the efg1 allele was complemented with the EFG1 gene.
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This might explain the slight differences in absolute ROS release
among strains containing two EFG1 alleles (SC5314, CAI4 URA3,
andHLC17Rev). Regarding EFG1, exponentially growing strains de-
leted for either one or two EFG1 alleles also triggered a strong ROS
response, although itwasdelayed.Forcells inpost-exponential-phase
growth, theROS responseof these strains dropped significantly com-
pared to the wild type. Interestingly, the absolute ROS levels induced
by these strains in exponential-phase and post-exponential-phase
growth were comparable. This indicates that Efg1 is crucial for re-
modeling cell wall structure during different cellular growth phases.
Remarkably, the macrophage ROS response did not correlate with
the -1,3-glucan exposure observed in the different strains, indicat-
ing that additional factors contribute significantly to the ROS re-
sponse.This is also true for thewild type: the apparent reduced-1,3-
glucan exposure of post-exponential-phase cells in comparison to
exponentially grown cells did not result in reduced ROS levels. In
contrast, an induction of 6- to 7-fold was observed. However, the
-1,3-glucan stained with the antibody might not represent the
-1,3-glucan molecules detected by immune receptors of the cell,
although this antibody is commonly used for discrimination of C.
albicans strains with different levels of exposed -1,3-glucan and
linked to recognition by innate immune cells (54).
As observed for macrophages, the C. albicans efg1/efg1 null mu-
tant induced significantly lower expression levels of some of the sig-
nature cytokines, such as TNF-, IL-4, and IL-23, in myeloid den-
dritic cells.Theproductionof IL-4, aTh2hallmarkcytokine,hasbeen
linked to ingestion of hyphae, while production of the Th1 hallmark
cytokine IL-12 is usually observed as a response to yeast-form fungal
cells (10). Therefore, the reduction in IL-4 expression in mDCs in-
gesting the efg1/efg1 strain may reflect its altered filamentation phe-
notype. The reduction of expression of TNF-, a classical inflamma-
tory cytokine,may be linked to changes inmannose structures of the
cell wall, since TNF- expression has been connected to stimulation
of mDCs by mannoproteins (36). Furthermore, IL-23 induction in
dendritic cells has been linked to -glucan, and strains devoid of
EFG1 contain significantly less of this component (7). Additionally,
we did not observe any significant reduction of the level of IL-10 or
IL-12. Thus, the differences in the transcriptional response most
likelywerenotcausedbyadifference in stimulusquantity (affectedby
cell size or amount) but rather were related to qualitative changes in
polysaccharide cell wall composition. This certainly would cause dif-
ferent availabilities of pathogen-associated molecular patterns
(PAMPs) eliciting the host immune response through the complex
interplay of dedicated and PAMP-specific pattern recognition recep-
tors (3).
The observed cell wall phenotypes of the efg1/efg1 null mutant, in
general, were not fully restored towild-type levels by reintegration of
only one functional allele of the EFG1 gene. In accordance with this
finding, the cell wall phenotypes of the initially created efg1/EFG1
heterozygous strain were often somewhere between those of the wild
type and the efg1/efg1 null mutant. However, in most cases, the phe-
notypesobserved for the efg1/EFG1heterozygous strainwere restored
to wild-type levels by reintroduction of a second functional EFG1
allele.Thephenotypesof the efg1/EFG1heterozygous strain (HLC17)
and thenullmutantwithone restoredEFG1 allele (HLC74)were also
consistent, although the functional alleles are located at different loci
(the original EFG1 locus and the LEU2 locus, respectively). The only
set of experiments where these two strains displayed partial differ-
ences was in the cytokine response of dendritic cells, but these results
correlate with the EFG1 expression patterns detected by quantitative
real-time PCR. It seems that reintegration of EFG1 into the LEU2
locus affected its expression, potentially due to truncation of the pro-
moter or because of a position effect of the locus.Only in this case did
the EFG1 allele position result in observable phenotypic differences.
The CAI4URA3 strain, aURA3 revertant of CAI4 (11), a ura3-
deficient parent of the EFG1-deficient strains, did behave very
similarly to the SC5314 wild-type strain with respect to cell wall
stability and composition, -1,3-glucan exposure, ROS response,
and DC immune response. Previously, URA3 expression changes
due to copy number and position were described to be important
for events such as hypha elongation and in vivo infection of mice
(26, 45). However, in this case, we did not observe any significant
changes in cell wall composition or immunogenicity ofC. albicans
that were dependent on URA3. Thus, all of the observed cell wall
changes can be attributed to the EFG1 deletion.
Taken together, our results strongly suggest that Efg1 defi-
ciency has a severe impact on the structural components of the cell
wall, in addition to the impact on cell wall protein expression
reported previously (47). It is evident that loss of one EFG1 allele
in the C. albicans genome already leads to severe changes in cell
wall homeostasis, with consequences for the immunogenicity of
these strains. The reduced immunogenicity might also help to
explain the slow clearance of the efg1/efg1mutant strain frommice
after infections in a tail vein model. Additionally, the major im-
pact of Efg1 on the cell wall might also help to explain the cell wall
differences and differential virulence reported for white and
opaque-phase cells, which express different Efg1 levels (1, 25, 51).
The identification of the structural changes in the cell wall
caused by loss of EFG1 reported in this work may help to explain
the exceptionally attenuated virulence ofC. albicans strains devoid
of EFG1, together with the other phenotypes characterizing EFG1,
including altered morphogenesis and differences in cell wall pro-
tein composition and general metabolism.
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